For patients with chronic obstructive pulmonary disease (COPD) with a history of exacerbations and a blood eosinophil count of at least 300 cells/µL, mepolizumab leads to a lower annualized rate of moderate or severe exacerbations, ...
May 12, 2025
0
0
Individuals taking steroid tablets for more than 3 months are over 6 times more likely to be diagnosed with adrenal insufficiency than those treated with nonsteroidal anti-inflammatory drugs, according to research presented ...
May 10, 2025
0
2
From the day we're born, we know how to breathe correctly. That means letting the diaphragm—the large, thin muscle just below the rib cage—do the work of drawing air into the lungs and letting it out. It's known as diaphragmatic ...
May 8, 2025
0
3
The incidence of infection by Mycobacterium abscessus is increasing in patients with cystic fibrosis, chronic obstructive pulmonary disease (COPD), and other chronic pulmonary diseases, leading to an accelerated lung function ...
May 8, 2025
0
25
Virtual pulmonary rehabilitation is a safe, effective alternative to traditional pulmonary rehabilitation programs for people with chronic obstructive pulmonary disease (COPD) who also require supplemental oxygen, according ...
May 1, 2025
0
0
Increased perceived stress may cause worsened respiratory symptoms and decreased quality of life in people with chronic obstructive pulmonary disease (COPD), according to a new study. The research is published in the March ...
Apr 29, 2025
0
1
Researchers at University of California San Diego found that cigarette smoking continues to decline across the United States, largely driven by young adults. Their study, published in JAMA Network Open on April 25, 2025, ...
Apr 25, 2025
0
0
A rare cell type in the lungs is essential to survival from the COVID-19 virus, a new study shows.
Apr 25, 2025
0
65
Alpha-1-antitrypsin is a so-called protease inhibitor, a type of enzyme inhibitor. It is produced in the liver but exerts its effects in the lungs, where it regulates immune cell activity. This regulation is crucial, and ...
Apr 17, 2025
0
11
Researchers from GlaxoSmithKline have reported that a single dose of the RSV vaccine, Arexvy (RSVPreF3 OA), provides effective protection against respiratory syncytial virus-related lower respiratory tract disease (RSV-LRTD) ...
